title: Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy.
abstract: Anti-beta-1-adrenergic receptor antibodies (anti-β1AR Abs) have long been implicated in the pathogenesis of dilated cardiomyopathy (DCM). It is believed that these autoantibodies bind to and constitutively stimulate the β1AR to promote pathological cardiac remodelling and β1AR desensitization and downregulation. The prevalence of anti-β1AR Abs in patients with DCM ranges from 26% to 60%, and the presence of these autoantibodies correlates with a poor prognosis. Several small studies have shown improvements in functional status, haemodynamics, and biomarkers of heart failure upon removal or neutralization of these antibodies from the sera of affected patients. Traditionally, removal of anti-β1AR Abs required immunoadsorption therapy with apheresis columns directed against human immunoglobulins (Igs) and subsequent i.v. Ig infusion, thereby essentially performing a plasma exchange transfusion. However, recent advances have allowed the development of small peptides and nucleotide sequences that specifically target and neutralize anti-β1AR Abs, providing a hopeful avenue for future drug development to treat DCM. Herein, we briefly review the clinical literature of therapy directed against anti-β1AR Abs and highlight the opportunity for further research and development in this area.
authors: Duke Clinical Research Institute, Durham, NC, USA. patel.priyesha@gmail.com
authors: Priyesh A
authors: PA
authors: Patel
authors: Adrian F
authors: AF
authors: Hernandez
mesh_terms: D000818:Animals; D001323:Autoantibodies; D015551:Autoimmunity / Q000276:immunology*; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D018342:Receptors, Adrenergic, beta-1 / Q000276:immunology* / Q000627:therapeutic use*
chemical_list: D001323:Autoantibodies; D018342:Receptors, Adrenergic, beta-1
keywords: Antibodies; Beta-1-adrenergic receptors; Cardiomyopathy; Immunoadsorption; Immunoglobulins
references: J Clin Apher. 2005 Oct;20(3):137-42
references: 15892087
references: J Am Coll Cardiol. 2000 May;35(6):1590-8
references: 10807465
references: Circulation. 2006 Apr 11;113(14):1807-16
references: 16567565
references: Am Heart J. 2005 Oct;150(4):729-36
references: 16209975
references: Am Heart J. 2010 May;159(5):809-16
references: 20435190
references: Am Heart J. 2006 Oct;152(4):697-704
references: 16996841
references: Circ J. 2009 Apr;73(4):602-7
references: 19246813
references: Circulation. 2007 Jul 24;116(4):399-410
references: 17620508
references: Circulation. 1997 Apr 15;95(8):1994-7
references: 9133505
references: Clin Pharmacol Ther. 2010 Apr;87(4):452-8
references: 20054293
references: Int J Cardiol. 2004 Dec;97(3):529-34
references: 15561344
references: J Am Coll Cardiol. 2002 Feb 20;39(4):646-52
references: 11849864
references: Circulation. 1999 Feb 9;99(5):649-54
references: 9950662
references: Immunobiology. 2012 May;217(5):511-20
references: 21820755
references: Circ Res. 1989 Jan;64(1):97-103
references: 2535798
references: Circ J. 2010 Jul;74(7):1372-8
references: 20501959
references: Circulation. 2002 Nov 5;106(19):2448-53
references: 12417541
references: Eur J Heart Fail. 2012 Dec;14(12):1374-88
references: 22892122
references: N Engl J Med. 2002 Nov 28;347(22):1806
references: 12456865
references: Int J Cardiol. 1996 May;54(2):191-5
references: 8803685
references: Am Heart J. 2006 Oct;152(4):712.e1-6
references: 16996843
references: Circulation. 1997 Jul 15;96(2):542-9
references: 9244223
references: J Mol Cell Cardiol. 1995 Jan;27(1):397-406
references: 7539084
references: J Am Coll Cardiol. 2001 Feb;37(2):418-24
references: 11216956
references: Am J Cardiol. 2004 May 1;93(9):1189-91
references: 15110223
references: Circulation. 2008 Sep 30;118(14 Suppl):S94-105
references: 18824777
references: PLoS Negl Trop Dis. 2011 Nov;5(11):e1375
references: 22069505
references: J Am Coll Cardiol. 2001 Jul;38(1):178-83
references: 11451270
references: J Clin Invest. 2004 May;113(10):1379-82
references: 15146232
references: Eur J Heart Fail. 2012 Nov;14(11):1230-9
references: 22968742
references: Circ Res. 2011 Oct 14;109(9):982-3
references: 21998296
references: Circ Res. 2001 Mar 30;88(6):578-86
references: 11282891
references: Z Kardiol. 1992;81 Suppl 4:79-83
references: 1283934
references: Circ Res. 2011 Oct 14;109(9):986-92
references: 21868696
references: J Autoimmun. 2003 Jun;20(4):345-50
references: 12791320
references: Circulation. 2000 Feb 1;101(4):385-91
references: 10653829
references: J Am Coll Cardiol. 2010 Feb 2;55(5):463-8
references: 20117461
references: Int J Cardiol. 2004 Dec;97(3):517-20
references: 15561342
references: Eur J Heart Fail. 2010 Jul;12(7):753-62
references: 20494925
references: Ther Apher Dial. 2006 Feb;10(1):42-8
references: 16556135
references: J Clin Invest. 1990 Nov;86(5):1658-63
references: 1700798
references: Autoimmunity. 2008 Sep;41(6):429-33
references: 18781468
references: Circ J. 2012;76(10):2449-55
references: 22850243
references: J Clin Invest. 2004 May;113(10):1419-29
references: 15146239
references: J Mol Cell Cardiol. 2009 Mar;46(3):300-8
references: 19103204